Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02882841 · ClinicalTrials.gov registry record · NA
MOlecular BIomarkers and Adherent and Invasive Escherichia Coli (AIEC) Detection Study In Crohn's Disease Patients
A NA study, sponsored by Enterome.
- Terminated
- Registry status
- NA
- Development phase
- 143
- Enrollment target
NCT02882841 is a NA study that was terminated before completion, run by Enterome. The registered enrollment target is 143 participants.
The verdict
NCT02882841, a NA study, was terminated before completion, sponsored by Enterome.
- TERMINATED
- Registry status
- NA
- Development phase
- 143 participants
- Enrollment target
Study Summary
The study is a multicenter, international descriptive study with a bio-collection in 300 evaluable Crohn's disease patients to be processed after usual biological tests via bioinformatics tools. At this time, this study has no impact neither on treatment nor on disease diagnostic, these will be based on usual medical practices and is no investigational product associated with the conduct of this study.
Interventions
- OTHER Biopsies, stool and blood collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 143 participants |
| Start Date | 2016-09 |
| Est. Completion | 2017-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02882841
The ClinicalTrials.gov registry entry for NCT02882841 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 143 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Enterome, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Biopsies, stool and blood collection is the first listed.
NCT02882841 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02882841 about?
NCT02882841 is a clinical study titled "MOlecular BIomarkers and Adherent and Invasive Escherichia Coli (AIEC) Detection Study In Crohn's Disease Patients". The study is a multicenter, international descriptive study with a bio-collection in 300 evaluable Crohn's disease patients to be processed after usual biological tests via bioinformatics tools. At this time, this study has no impact neither on treatment nor on disease diagnostic, these will be bas...
What is the current status of trial NCT02882841?
This trial is currently terminated. It is a NA study. The enrollment target is 143 participants. The study started on 2016-09. Estimated completion is 2017-12.
What interventions are being tested in trial NCT02882841?
The interventions under investigation include: Biopsies, stool and blood collection (OTHER).
Who is sponsoring clinical trial NCT02882841?
This trial is sponsored by Enterome, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.